Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-21 @ 11:19 PM
Study NCT ID:
NCT02349451
Status:
COMPLETED
Last Update Posted:
2017-08-04
First Post:
2015-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-23
First Submit QC Date:
None
Study First Post Date:
2015-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-27
Results First Submit QC Date:
None
Results First Post Date:
2017-08-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-02
Last Update Post Date:
2017-08-04
Last Update Post Date Type:
ACTUAL